PNV 3.37% $2.58 polynovo limited

Ann: FDA feedback on Pivotal Protocol, page-5

  1. 2,740 Posts.
    lightbulb Created with Sketch. 1320
    Yep, long game on that one anyway.

    Waiting on Hernia factory completion and commissioning, as that is key to establish the timeline to commercialisation for Syntrel in the back half of next year....this being slowed down by Dan the ban.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.